The Fullerene Therapeutics team has deep research and development experience in pharmaceutical products, new company startup and development, and patent law. Parts of the team have worked together for nearly forty years, and each member of the team has deep experience in his/her area of expertise.
Chief Executive Officer and Acting Executive Chairman
Dr. O’Connell holds a B.S. in biological sciences from Fordham University, M.S. in natural sciences/chemistry and Ph.D. in chemistry/immunology from Roswell Park Cancer Institute, Buffalo, NY. Dr. O’Connell received her NIH NRSA postdoctoral training in immunology and molecular biology at NY Medical College and in immunochemistry at Memorial Sloan-Kettering Cancer Center where she was associated professionally for ten years as a cancer research scientist and senior research administrator. Following her J.D. from Fordham University School of Law, she was associated with Kenyon & Kenyon, LLP in pharmaceutical patent practice. Dr. O’Connell expects her MBA and M.S. in Healthcare Leadership degrees from Cornell University Johnson Graduate School of Management and Weill Cornell Medical College in 2019, bringing her expertise to focus on commercializing C3.
Dr. O’Connell has taught medical microbiology, immunology and molecular immunology at NYMC and federal regulatory agency policy and intellectual property law as Associate Dean for Academic Affairs at Fordham University. Dr. O’Connell is admitted to practice before the U.S. Patent and Trademark Office, U.S. Supreme Court, U.S. CAFC, U.S. District Courts in NY and NJ and NJ state bar.
Dr. Dugan, the inaugural holder of the Larry L. Hillblom Chair in Geriatric Medicine at the University of California San Diego (UCSD), recently joined the faculty at Vanderbilt University Medical Center. She now directs Vanderbilt’s Division of Geriatric Medicine, a division of the Department of Medicine. She is board certified in both internal medicine and geriatrics. Dr. Dugan’s research focuses on the basic biology of nervous system aging and the role of free radical neurobiology in aging and neurodegenerative diseases. Her recent work has focused on rationally designed buckminsterfullerene derivatives as antioxidants and neuroprotective agents.
Dr. Dugan holds joint appointments in UC San Diego’s Departments of Medicine and Neurosciences. She received her SB in Life Sciences from the Massachusetts Institute of Technology, and her M.D. from the Ohio State University College of Medicine. She completed residency training in Internal Medicine at the UC San Francisco Children’s Hospital of San Francisco, and served as Chief Resident in Medicine her final year. She was a Presidential Scholar as an undergraduate and has been the recipient of a Dana Research Fellowship, a Paul Beeson Physician Scholars Award through the American Federation for Aging Research, a Hartford Foundation Award for Geriatric Research, a Hartford Leadership Scholars in Geriatric Medicine Award, the Kopolow Award for Geriatric Psychiatry and Neurology, and an Innovation Award from the St. Louis Academy of Sciences.
Chief Scientific Officer
Dr. Pellegrino is a practicing neurologist and clinical researcher and is located in Hot Springs, Arkansas. Dr. Pellegrino has been Principal Investigator of more than 180 FDA Phase II and III clinical trials tests on past neurological and medical treatments.
Dr. Pellegrino is a former National Multiple Sclerosis Society fellow, Trustee of the American Academy of Pharmaceutical Physicians, and winner of the Ten Outstanding Young Americans award for 1995. He was awarded a Medical Scientist Training Program scholarship and received his M.D. and Ph.D. in neuroscience from the Albert Einstein College of Medicine of Yeshiva University, Bronx, NY. His post doctoral clinical and research training was conducted at Yale University Department of Pharmacology in New Haven CT., Columbia University Department of Neurology in New York City, NY, Penn State University Hospital Department of Neurology, in Hershey, PA, and the Westchester Medical Center Department of Internal Medicine in Westchester, NY.
General Counsel, Secretary and Board Member
Mr. Root is an attorney with 30 years of experience developing, protecting, and exploiting patent portfolios. He is the author of “Rules of Patent Drafting: Guidelines from Federal circuit Case Law”, published by Oxford University Press in 2011. He previously served as General Counsel to sizeable companies, both public and private.
Mr. Root received a J.D., magna cum laude, from Wake Forest University, and a B.S. from the United States Military Academy, West Point, NY. He engaged in private practice with the New York office of Kenyon & Kenyon. Before attending law school, Mr. Root held engineering and production management positions with Corning and General Electric.